J.&J. to Resume Its Covid Vaccine Rollout in Europe
The agency says the Johnson & Johnson coronavirus vaccine should have a warning for a potential risk for rare blood clots even though it believes the shot’s benefits outweigh risks. The agency did not recommend stopping use of the vaccine.
